Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arati Sharma

Showing results (41-50 of 89) with videos related to

Pageof 9
Sort By:
Bioorganic & Medicinal Chemistry Letters|February 16, 2010
Synthesis and characterization of a novel iNOS/Akt inhibitor Se,Se'-1,4-phenylenebis(1,2-ethanediyl)bisisoselenourea (PBISe)--against colon cancerDhimant Desai, SubbaRao V Madhunapantula, Krishnegowda Gowdahalli, et al.
Case Reports in Dentistry|October 23, 2015
Fabrication of Closed Hollow Bulb Obturator Using Thermoplastic Resin MaterialBidhan Shrestha, E Richard Hughes, Raj Kumar Singh, et al.
Cancers|February 27, 2026
Advances in the Understanding of Akt Signaling in Cancers and the Potential of Inhibiting Akt-Driven Tumors Using Small Molecule Inhibitors: An OverviewJamuna Bai Aswathanarayan, Rimshia Naaz, Shalini H Doreswamy, et al.
Cancer Research|September 17, 2008
Targeting V600EB-Raf and Akt3 using nanoliposomal-small interfering RNA inhibits cutaneous melanocytic lesion developmentMelissa A Tran, Raghavendra Gowda, Arati Sharma, et al.
Cancer Research|August 17, 2006
Targeting mitogen-activated protein kinase/extracellular signal-regulated kinase kinase in the mutant (V600E) B-Raf signaling cascade effectively inhibits melanoma lung metastasesArati Sharma, Melissa A Tran, Shile Liang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 12, 2009
Targeting Akt3 signaling in malignant melanoma using isoselenocyanatesArati Sharma, Arun K Sharma, Subbarao V Madhunapantula, et al.
International Journal of Molecular Sciences|July 27, 2022
Therapeutic Benefits of Selenium in Hematological MalignanciesMelanie A Ehudin, Upendarrao Golla, Devnah Trivedi, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|April 26, 2022
Interleukin-4 treatment reduces leukemia burden in acute myeloid leukemiaFenghua Qian, Brooke E Arner, Kathleen M Kelly, et al.
Cancer Prevention Research (Philadelphia, Pa.)|November 25, 2010
Melanoma chemoprevention in skin reconstructs and mouse xenografts using isoselenocyanate-4Natalie Nguyen, Arati Sharma, Nhung Nguyen, et al.
Cancer Biology & Therapy|August 31, 2017
Identification of WEE1 as a target to make AKT inhibition more effective in melanomaOmer F Kuzu, Raghavendra Gowda, Arati Sharma, et al.
Pageof 9

Showing results (41-50 of 89) with videos related to

Sort By:
Pageof 9
Bioorganic & Medicinal Chemistry Letters|February 16, 2010
Synthesis and characterization of a novel iNOS/Akt inhibitor Se,Se'-1,4-phenylenebis(1,2-ethanediyl)bisisoselenourea (PBISe)--against colon cancerDhimant Desai, SubbaRao V Madhunapantula, Krishnegowda Gowdahalli, et al.
Case Reports in Dentistry|October 23, 2015
Fabrication of Closed Hollow Bulb Obturator Using Thermoplastic Resin MaterialBidhan Shrestha, E Richard Hughes, Raj Kumar Singh, et al.
Cancers|February 27, 2026
Advances in the Understanding of Akt Signaling in Cancers and the Potential of Inhibiting Akt-Driven Tumors Using Small Molecule Inhibitors: An OverviewJamuna Bai Aswathanarayan, Rimshia Naaz, Shalini H Doreswamy, et al.
Cancer Research|September 17, 2008
Targeting V600EB-Raf and Akt3 using nanoliposomal-small interfering RNA inhibits cutaneous melanocytic lesion developmentMelissa A Tran, Raghavendra Gowda, Arati Sharma, et al.
Cancer Research|August 17, 2006
Targeting mitogen-activated protein kinase/extracellular signal-regulated kinase kinase in the mutant (V600E) B-Raf signaling cascade effectively inhibits melanoma lung metastasesArati Sharma, Melissa A Tran, Shile Liang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 12, 2009
Targeting Akt3 signaling in malignant melanoma using isoselenocyanatesArati Sharma, Arun K Sharma, Subbarao V Madhunapantula, et al.
International Journal of Molecular Sciences|July 27, 2022
Therapeutic Benefits of Selenium in Hematological MalignanciesMelanie A Ehudin, Upendarrao Golla, Devnah Trivedi, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|April 26, 2022
Interleukin-4 treatment reduces leukemia burden in acute myeloid leukemiaFenghua Qian, Brooke E Arner, Kathleen M Kelly, et al.
Cancer Prevention Research (Philadelphia, Pa.)|November 25, 2010
Melanoma chemoprevention in skin reconstructs and mouse xenografts using isoselenocyanate-4Natalie Nguyen, Arati Sharma, Nhung Nguyen, et al.
Cancer Biology & Therapy|August 31, 2017
Identification of WEE1 as a target to make AKT inhibition more effective in melanomaOmer F Kuzu, Raghavendra Gowda, Arati Sharma, et al.
Pageof 9